J. Gillmore

A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosis

P. Hawkins, C. Whelan, A. Wechalekar, 2014, Leukemia.

PS1373 A TWENTY-FOUR YEAR EXPERIENCE OF AUTOLOGOUS STEM CELL TRANSPLANTATION FOR LIGHT CHAIN AMYLOIDOSIS PATIENTS IN THE UNITED KINGDOM

A. Petrie, P. Hawkins, M. Fontana, 2019, HemaSphere.

Amyloidosis and the liver.

L. Lovat, J. Gillmore, P. Hawkins, 1999, Journal of hepatology.

AB1064 Carpal tunnel biopsy and bone scintigraphy using the technetium-3,3-diphosphono-1,2-propanodicarboxylic acid (99M) (TC-DPD) tracer can identify clinically silent cardiac amyloidosis at a potentially treatable stage

M. Fontana, N. Goddard, T. Youngstein, 2017 .

THU0076 Disease-modifying treatment regimens have been insufficient to reduce the incidence of systemic aa amyloidosis associated with rheumatoid arthritis in contrast to a significant reduction in those with juvenile idiopathic arthritis

M. Fontana, C. Whelan, T. Youngstein, 2017 .

Hereditary renal amyloidosis associated with variant lysozyme in a large English family.

D. Booth, M. Pepys, P. Hawkins, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.